Bladder cancer and exeRcise trAining during intraVesical thErapy

The BRAVE Study is a research study from the Behavioural Medicine Laboratory at the University of Alberta that aims to investigate the viability, efficacy, and safety of aerobic exercise during and after intravesical therapy for bladder cancer.

The BRAVE Study will help to understand whether exercise helps patients feel and function better, and possibly even reduce the risk of cancer recurrence and progression.

We will ask some patients to do a supervised exercise program during the 6 weeks of therapy and the 6 weeks after their treatment while other patients will be asked not to exercise for that 3 month period. We will compare the 2 groups on how they fare with their bladder cancer treatment.

There is no guarantee that exercise will provide any direct benefits to these patients. Moreover, we do not know what effects, if any, exercise may have on the chances of bladder cancer recurrence or progression. However, based on the results of this study, it is hoped that further research may be conducted to improve long-term, patient care in this setting.

The BRAVE Study was granted approval by the Health Research Ethics Board of Alberta-Cancer Committee (HREBA-CC: #20-0184).

This website provides information for potential and existing BRAVE Study participants. Recruitment will occur at the Northern Alberta Urology Centre in Edmonton, Alberta, Canada where potential participants will be approached directly by BRAVE Study staff.

For further information, please contact Fernanda - Study Coordinator at (780) 492-2829 or arthuso@ualberta.ca